Revascularization in Heart Failure: Coronary Bypass or Percutaneous Coronary Intervention?

Heart Failure Clinics

Volumn 3, Issue 2, 2007, Pages 211-228

  Pusca, Sorin V ^a   Puskas, John D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGINA PECTORIS; CORONARY ARTERY BYPASS GRAFT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MORTALITY; OUTCOME ASSESSMENT; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; SURVIVAL RATE; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; DEATH, SUDDEN, CARDIAC; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MYOCARDIAL REVASCULARIZATION; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; STROKE VOLUME; TREATMENT OUTCOME;

EID: 34447575709     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2007.05.002     Document Type: Review

References (57)

1. Bourassa M.G., Gurne O., Bangdiwala S.I., et al. Natural history and patterns of current practice in heart failure. The studies of left ventricular dysfunction (SOLVD) investigators. J Am Coll Cardiol 4 Suppl A (1993) 14A-19A
2. Anonymous (The CONSENSUS trial Study group). Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 316 (1987) 1429-1435
3. Anonymous (The SOLVD Investigators). Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325 (1991) 293-302
4. Packer M., Bristow M.R., Cphn J.N., et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
5. Anonymous (MERIT-HF Study Group). Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 353 (1999) 2001-2007
6. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341 (1999) 709-717
7. Miller W.L., Tointon S.K., Hodge D.O., et al. Long-term outcome and the use of revascularization in patients with heart failure, suspected ischemic heart disease, and large reversible myocardial perfusion defects. Am Heart J 143 (2002) 904-909
8. Halkin A., Singh M., Nikolsky E., et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction the CADILLAC risk score. J Am Coll Cardiol 45 (2005) 1397-1405
9. Eagle K.A., Guyton R.A., and The American College of Cardiology/American Heart Association Task Force on ACC/AHA PRACTICE GUIDELINES (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association task force on practice guidelines developed in collaboration with the American association for thoracic surgery and the society of thoracic surgeons. Circulation 110 (2004) 340-437
10. Tarakji K.G., Brunken R., McCarthy P.M., et al. Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction. Circulation 113 (2006) 230-237
11. Bourque J.M., Hasselblad V., Velazquez E.J., et al. Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am Heart J 146 (2003) 621-627
12. Allman K.C., Shaw L.J., Hachamovitch R., et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
13. Elefteriades J.A., Tolis G., Levi E., et al. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 22 (1993) 1411-1417
14. Meluzín J., Cerný J., Frélich M., et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 32 (1998) 912-920
15. Myers W.O., Gersh B.J., Fisher L.D., et al. Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg 44 (1987) 471-486
16. Myers W.O., Schaff H.V., Gersh B.J., et al. Improved survival of surgically treated patients with triple vessel coronary artery disease and severe angina pectoris: a report from the Coronary Artery Surgery Study (CASS) registry. J Thorac Cardiovasc Surg 97 (1989) 487-495
17. Pagley P.R., Beller G.A., Watson D.D., et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 96 (1997) 793-800
18. Baker D.W., Jones R., Hodges J., et al. Management of heart failure, III: the role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 272 (1994) 1528-1534
19. Appoo J., Norris C., Merali S., et al. Long-term outcome of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction. Circulation 110 Suppl II (2004) II13-II17
20. Lorusso R., LaCanna G., Ceconi C., et al. Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium. Eur J Cardiothorac Surg 20 (2001) 937-948
21. Shapira I., Isakov A., Yakirevich V., et al. Long-term results of coronary artery bypass surgery in patients with severely depressed left ventricular function. Chest 108 (1995) 1546-1550
22. Ascione R., Narayan P., Rogers C.A., et al. Early and midterm clinical outcome in patients with severe left ventricular dysfunction undergoing coronary artery surgery. Ann Thorac Surg 76 3 (2003) 793-799
23. Goldstein D.J., Beauford R.B., Luk B., et al. Multivessel off-pump revascularization in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 24 1 (2003) 72-80
24. Carr J.A., Haithcock B.E., Paone G., et al. Long-term outcome after coronary artery bypass grafting in patients with severe left ventricular dysfunction. Ann Thorac Surg 74 5 (2002) 1531-1536
25. Bouchart F., Tabley A., Litzler P.Y., et al. Myocardial revascularization in patients with severe ischemic left ventricular dysfunction. Long term follow-up in 141 patients. Eur J Cardiothorac Surg 20 6 (2001) 1157-1162
26. Trachiotis G.D., Weintraub W.S., Johnston T.S., et al. Coronary artery bypass grafting in patients with advanced left ventricular dysfunction. Ann Thorac Surg 66 (1998) 1632-1639
27. Veenhuyzen G.D., Singh S.N., McAreavey D., et al. Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction. Circulation 104 (2001) 1489-1493
28. Yusuf S., and Zucker D. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 (1994) 563-570
29. O'Connor C.M., Velazquez E.J., Gardner L.H., et al. Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank). Am J Cardiol 90 (2002) 101-107
30. Darwazah A.K., Sham'a R.A.A., Hussein E., et al. Myocardial revascularization in patients with low ejection fraction ≤35%: effect of pump technique on early morbidity and mortality. J Card Surg 21 (2006) 22-27
31. Elefteriades J.A., Morales D.L.S., Gradel C., et al. Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < 30%. Am J Cardiol 79 (1997) 1573-1578
32. Nishi H., Miyamoto S., Takanashi S., et al. Complete revascularization in patients with severe left ventricular dysfunction. Ann Thorac Cardiovasc Surg 9 (2003) 111-116
33. Hochberg M.S., Parsonnet V., Gielchinsky I., et al. Coronary artery bypass grafting in patients with drastic impairment of function of the left ventricle. J Thorac Cardiovasc Surg 86 (1983) 519-527
34. Hausmann H., Warnecke H., Ennker J., et al. Survival predictors in patients with a left ventricular ejection fraction of 10-30% receiving a coronary bypass: analysis of preoperative variables. Cardiovasc Surg 2 (1993) 558-562
35. Kaul E.K., Agnihotri A.K., Fields B.L., et al. Coronary artery bypass grafting in patients with an ejection fraction of twenty percent or less. J Thorac Cardiovasc Surg 111 (1996) 1001-1012
36. Argenziano M., Spotnitz H.M., Whang W., et al. Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction analysis of the coronary artery bypass grafting patch trial database. Circulation 100 Suppl II (1999) II119-II124
37. Bigger J.T., and for the Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. N Engl J Med 337 (1997) 1569-1575
38. DeRose Jr. J.J., Toumpoulis I.K., Balaram S.K., et al. Preoperative prediction of long-term survival after coronary artery bypass grafting in patients with low left ventricular ejection fraction. J Thorac Cardiovasc Surg 129 (2005) 314-321
39. Topkara V.K., Cheema F.H., Kesavaramanujam S., et al. Coronary artery bypass grafting in patients with low ejection fraction. Circulation 112 Suppl I (2005) I344-I350
40. Tjan T.D.T., Kondruweit M., Scheld H.H., et al. The bad ventricle-revascularization versus transplantation. J Thorac Cardiovasc Surg 48 (2000) 9-14
41. Afridi I., Grayburn P.A., Panza J.A., et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 32 (1998) 921-926
42. Sawada S., Bapat A., Vaz D., et al. Incremental value of myocardial viability for prediction of long-term prognosis in surgically revascularized patients with left ventricular dysfunction. J Am Coll Cardiol 42 (2003) 2099-2105
43. Mickleborough L.L., Carson S., Tamariz M., et al. Results of revascularization in patients with severe left ventricular dysfunction. J Thorac Cardiovasc Surg 119 3 (2000) 550-557
44. Guyton R.A. Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease. Ann Thorac Surg 81 (2006) 1949-1957
45. Hoffman S.N., TenBrook Jr. J.A., Wolf M.P., et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41 (2003) 1293-1304
46. Keelan P.C., Johnston J.M., Koru-Sengul T., et al., (for the Dynamic Registry Investigators). Comparison of in-hospital and one-year outcomes in patients with left ventricular ejection fractions <40%, 41% to 49%, and >50% having percutaneous coronary revascularization. Am J Cardiol 91 (2003) 1168-1172
47. Toda K., Mackenzie K., Mehra M.R., et al. Revascularization in severe ventricular dysfunction (15% < LVEF < 30%): a comparison of bypass grafting and percutaneous intervention. Ann Thorac Surg 74 (2002) 2082-2087
48. O'Keefe J.H., Allan J.J., McCallister B.D., et al. Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction <40%. Am J Cardiol 71 (1993) 897-901
49. Berger P.B., Velianou J.L., Vlachos H.A., et al., for the BARI Investigators. Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy results from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol 38 (2001) 1440-1449
50. Hillis G.S., Zehr K.J., Williams A.W., et al. Outcome of patients with low ejection fraction undergoing coronary artery bypass grafting renal function and mortality after 3.8 years. Circulation 114 Suppl I (2006) I414-I419
51. Brener S.J., Lytle B.W., Casserly I.P., et al. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109 (2004) 2290-2295
52. Morrison D.A., Sethi G., Sacks J., et al., For the Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. J Am Coll Cardiol 38 (2001) 143-149
53. Sedlis S.P., Ramanathan K.B., Morrison D.A., et al. Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the awesome randomized trial and registry). Am J Cardiol 94 (2004) 118-120
54. Morrison D.A., Sethi G., Sacks J., et al., For the Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME). . Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass the VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol 39 (2002) 266-273
55. Hordijk-Trion M., Lenzen M., Wijns W., et al., (for the EHS-CR Investigators). Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on coronary revascularization. Eur Heart J 27 (2006) 671-678
56. Hannan E.L., Racz M.J., Walford G., et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352 (2005) 2174-2183
57. Tsuyuki R.T., Shrive F.M., Galbraith P.D., et al., for the APPROACH Investigators. Revascularization in patients with heart failure. CMAJ 175 4 (2006) 361-365